RWMG
IOBT

Redwood Wealth Management Group’s IO Biotech IOBT Stock Holding History

Redwood Wealth Management Group’s Portfolio IOBT Stock Details IOBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,166
Closed -$4.87K – 607
2024
Q2 		$4.87K Buy
+4,166
New +$5.82K ﹤0.01% 744

Other funds holding IOBT

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Redwood Wealth Management Group's IOBT Position: Q3 2024 in Review

Redwood Wealth Management Group sold out of IO Biotech (IOBT) in Q3 2024, closing a stake of 4,166 shares — an estimated $4.87K sold.

Redwood Wealth Management Group first reported a position in IOBT in Q2 2024 and held it in 1 quarter. The position peaked at $4.87K in Q2 2024. 20 funds tracked by Wall St. Rank hold IOBT as of Q3 2024.

  • Redwood Wealth Management Group reported no remaining IO Biotech position as of Q3 2024 after selling out during the quarter.
  • Redwood Wealth Management Group sold 4,166 IO Biotech shares in Q3 2024, an estimated $4.87K.
  • Redwood Wealth Management Group first reported a position in IO Biotech in Q2 2024 and held it in 1 quarter.
  • Redwood Wealth Management Group's IO Biotech position peaked at $4.87K in Q2 2024.
  • 20 funds tracked by Wall St. Rank held IO Biotech as of Q3 2024.

Based on Redwood Wealth Management Group's 13F filing for Q3 2024, filed 13 Nov 2024.